These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86. A retrospective study of the pharmacokinetics of heparin. Estes JW; Pelikan EW; Krüger-Thiemer E Clin Pharmacol Ther; 1969; 10(3):329-37. PubMed ID: 5795800 [No Abstract] [Full Text] [Related]
87. The properties of plasma antithrombin III before and after freezing at -20 degrees C. Mackie IJ; Bull H; Brozovic M Thromb Res; 1980 Dec 1-15; 20(5-6):697-700. PubMed ID: 7233392 [No Abstract] [Full Text] [Related]
88. Dynamic Covalent Identification of an Efficient Heparin Ligand. Corredor M; Carbajo D; Domingo C; Pérez Y; Bujons J; Messeguer A; Alfonso I Angew Chem Int Ed Engl; 2018 Sep; 57(37):11973-11977. PubMed ID: 29998599 [TBL] [Abstract][Full Text] [Related]
92. Preparation and Characterization of Low Molecular Weight Heparin by Liquid Phase Plasma Method. Lee DJ; Kim H; Kim BH; Park YK; Lee H; Park SH; Jung SC J Nanosci Nanotechnol; 2015 Aug; 15(8):6210-3. PubMed ID: 26369227 [TBL] [Abstract][Full Text] [Related]
93. [Molecular nature of histamine-heparin complex]. Erzinkian KL; Alaverdian KG; Nizhniĭ SV Izv Akad Nauk SSSR Biol; 1977; (6):813-8. PubMed ID: 604371 [No Abstract] [Full Text] [Related]
94. [The molecular mechanism of the fibrinogen--heparin complex formation reaction]. Rozenfel'd MA; Erzinkain KL; Piruzian LA Izv Akad Nauk SSSR Biol; 1975; (3):419-27. PubMed ID: 1214026 [No Abstract] [Full Text] [Related]
95. [Characteristics of heparin. II. Chromatographic behavior and biologic activity]. Ferrari L; Boffi C Farmaco Prat; 1970 Feb; 25(2):130-41. PubMed ID: 5515618 [No Abstract] [Full Text] [Related]